HOME > TOP STORIES

TOP STORIES

BUSINESS Battle Begins for Blopress Generics

December 16, 2014
REGULATORY LDP Healthcare Big Names Cruise to Victory in Lower House Poll

December 15, 2014
REGULATORY Outline of New Global Clinical Trial Guidelines Agreed On at ICH Confab in Lisbon

December 12, 2014
REGULATORY Elplat, Elaspol Generics to Join NHI Price List on Dec. 12

December 11, 2014
REGULATORY Annual NHI Price Cuts Draw Fire from All Sides at Ryukaikon Council

December 10, 2014
REGULATORY Japan NIH to Have Drug Discovery Support Unit

December 9, 2014
BUSINESS April-September Sales Drop 21.5% for Major Long-Listed Products

December 8, 2014
BUSINESS Daiichi Sankyo to Harness Ties with Cardiologists in Lixiana Promotion

December 8, 2014
BUSINESS Nippon Chemiphar to Set Up Plant in Vietnam, Operation Launch Slated in 2018

December 5, 2014
REGULATORY ICH Makes Progress Toward Greater Inclusivity, Agrees to Establish Assembly at November Meeting in Lisbon

December 4, 2014
REGULATORY Pharma Industry Girding for Post-Election Lobbying on R&D Tax Credit

December 3, 2014
BUSINESS Otsuka to Buy US Firm Avanir Pharmaceuticals to Fully Enter Neurology Market

December 3, 2014
BUSINESS Takeda’s Proteasome Inhibitor Ixazomib Granted Breakthrough Therapy Designation by US FDA

December 3, 2014
BUSINESS A-zas Looks to Offer E-Detailing App, Big-Data Analyses to More Firms

December 2, 2014
REGULATORY PAFSC’s Second Committee Backs Approval of Novartis’s Secukinumab

December 1, 2014
BUSINESS EPS Gives 400 Workers CDISC Training to Set Itself Apart from Rival CROs

November 28, 2014
INTERVIEW Gilead Starting from Scratch to Build Solo Sales Regime: Japan Pres.

November 28, 2014
ACADEMIA Avigan’s Efficacy in Ebola “Unknown” with No Corroborative Data: NIID Official

November 27, 2014
BUSINESS Kaken Banking on Clenafin to Boost Dermatology Biz

November 27, 2014
REGULATORY Debates on Yearly NHI Price Cuts Put on Hold as Attention Turns to Election

November 26, 2014

ページ

Chuikyo Debate on FY2026 Drug Pricing Reform

Chuikyo OKs New CEA Handling, with Third-Party Verification Ahead

Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…

COMMENTARY

Adaptation, Diversification Key as Drug Wholesalers Face Profit Squeeze

By Tatsuya Otsuka

Japan’s leading pharmaceutical wholesalers are bracing for a second consecutive year of profit declines, underscoring the growing challenge of generating…

COLUMN

More Positions, More Candidates: A Snapshot of Movement in Japan’s Pharma Industry

By Philip Carrigan

Recent trends are creating a fascinating push-and-pull effect in the talent market. We’re seeing more positions opening up, but also a greater number of candidates available, particularly in the fields of rare diseases and oncology. This “more positions, more candidates”…